| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |